Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 3

The Fabry Family Determined as a Result of the Screening of the Transplanted Patients: A Single-Center Screening

Pages
254–258
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Again, the family had only one male member with the mutation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Fabry disease (FD) is an X-linked lysosomal storage disorder that arises from a decreased activity of α-galactosidase A.
📊
Key Findings & Data:Methods: We were able to screen 200 transplanted patients at the University of Health Science, Haydarpasa Numune Training and Research Center. α-Gal A activity was used for screening of the male patients.
💡
Conclusion & Impact:Again, the family had only one male member with the mutation.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Introduction: Fabry disease (FD) is an X-linked lysosomal storage disorder that arises from a decreased activity of α-galactosidase A. With this study, we evaluated an FD family, which was detected after the screen of transplanted patients. Methods: We were able to screen 200 transplanted patients at the University of Health Science, Haydarpasa Numune Training and Research Center. α-Gal A activity was used for screening of the male patients. Gene analysis was performed for all female transplanted patients. Results: Among 200 patients, one 35 years old female patient had a genetic mutation, which was c.376A>G (p=S126G) heterozygous. She received a renal kidney from her sister in 2015. Genetic analysis of this female donor also revealed the same genetic variation. Starting with this index patient, we communicate with available 38 family members. Among these family members, the genetic analysis was performed to 22 family members. Twelve and 10 family members had negative and positive results, respectively. We could not communicate with 12 family members. Only one male family member had positive result and was the nephew of the index case. Discussion and Conclusion: Eleven family members had positive results for genetic analysis. An 87 years old aunt showed the asymptomatic nature of the disease. Again, the family had only one male member with the mutation.

🔖

Cite This Article

YALÇIN, C. Ö., BAŞ, S., ÖĞÜTMEN, M. B. (2020). The Fabry Family Determined as a Result of the Screening of the Transplanted Patients: A Single-Center Screening. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 3, 254–258. https://ajindex.com/articles/158618

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Germain DP. Fabry disease. Orphanet J Rare Dis 2010;5:30
  2. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995;333:288–93
  3. MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 2001;38:769 -75
  4. Ersözlü S, Desnick RJ, Huynh-Do U, Canaan-Kühl S, Barbey F, Genitsch V, et al. Long-term Outcomes of Kidney Transplantation in Fabry Disease. Transplantation 2018;102:1924–1933
  5. Ojo A, Meier-Kriesche HU, Friedman G, Hanson J, Cibrik D, Leichtman A, et al. Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation 2000;69:2337– 9
  6. Inderbitzin D, Avital I, Largiadèr F, Vogt B, Candinas D. Kidney transplantation improves survival and is indicated in Fabry's disease. Transplant Proc 2005;37:4211–4
  7. Popli S, Molnar ZV, Leehey DJ, Daugirdas JT, Roth DA, Adams MB, et al. Involvement of renal allograft by Fabry's disease. Am J Nephrol 1987;7:316–8
  8. Odani K, Okumi M, Honda K, Ishida H, Tanabe K. Kidney transplantation from a mother with unrecognized Fabry disease to her son with low α-galactosidase A activity: A 14-year followup without enzyme replacement therapy. Nephrology (Carlton) 2016;21:57–9
  9. Turkmen K, Guclu A, Sahin G, Kocyigit I, Demirtas L, Erdur FM, et al. The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study. Kidney Blood Press Res 2016;41:1016–24
  10. Kalkan Uçar S, Sozmen E, Duman S, Başçi A, Çoker M. Alphagalactosidase A activity levels in Turkish male hemodialysis patients. Ther Apher Dial 2012;16:560–5
  11. Sayilar EI, Ayar Y, Yavuz M. Prevalence of Fabry disease among Turkish dialysis patients: Data from hemodialysis centers in Bursa province. Clin Nephrol 2016;85:165–72
  12. Yılmaz M, Uçar SK, Aşçı G, Canda E, Tan FA, Hoşcoşkun C, et al. Preliminary Screening Results of Fabry Disease in Kidney Transplantation Patients: A Single-Center Study. Transplant Proc 2017;49:420–4
  13. Gal A, Hughes DA, Winchester B. Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group. J Inherit Metab Dis 2011;34:509–14
  14. Dajnoki A, Fekete G, Keutzer J, Orsini JJ, De Jesus VR, Chien YH, et al. Newborn screening for Fabry disease by measuring GLA activity using tandem mass spectrometry. Clin Chim Acta